In vivo antileishmanial properties of pentavalent antimonial compounds.
D000818:Animals; D000965:Antimony / Q000494:pharmacology*; D000967:Antimony Sodium Gluconate / Q000494:pharmacology*; D005942:Gluconates / Q000494:pharmacology*; D007891:Leishmania / Q000187:drug effects*; D008536:Meglumine; D000077485:Meglumine Antimoniate; D051379:Mice; D008815:Mice, Inbred Strains; D009942:Organometallic Compounds
D005942:Gluconates; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony; D000967:Antimony Sodium Gluconate